In a world first, CRCHUM researcher Martine Tétreault and her team identify a set of biomarkers that could someday make it easy to spot the disease in a patient's blood sample.

Can clinicians predict how Parkinson’s disease or Lewy body dementia will progress in the brain? UdeM medical professor Shady Rahayel looks into the question.

A study led by UdeM’s Sarah Lippé demonstrates that artificial intelligence can quickly and accurately assess brain maturity in babies, enabling early detection of developmental disorders.

Millions of kidney patients stand to benefit from early diagnosis and prevention thanks to the breakthrough by scientists at the CRCHUM and UdeM.

Graduating dentist Angélique Thibault believes hypnosis could enhance dental patients' well-being — but first, dentists have to be trained in the technique.

UdeM’s Carole Anglade is exploring the benefits of choral singing for those who have difficulty communicating after a stroke.

As he takes over from Yoshua Bengio as scientific director IVADO, Aaron Courville reflects on what artificial intelligence needs: more optimism.

After getting next-generation gene therapy at Montreal's CHU Sainte-Justine, an 18-year-old patient with chronic granulomatous disease sees his white cells come back.

An UdeM study examines the effectiveness of giving a special poison to mice to kill the ticks that carry Lyme disease.

Endocrinologist Hélène Lavoie discusses this complex and often misunderstood hormonal change in men, which occurs gradually and unevenly starting as young as age 30.